GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » PB Ratio

WDB coco Co (TSE:7079) PB Ratio : 2.16 (As of Dec. 12, 2024)


View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-12), WDB coco Co's share price is 円3445.00. WDB coco Co's Book Value per Share for the quarter that ended in Sep. 2024 was 円1,597.93. Hence, WDB coco Co's PB Ratio of today is 2.16.

Good Sign:

WDB coco Co Ltd stock PB Ratio (=2.17) is close to 5-year low of 2.04

The historical rank and industry rank for WDB coco Co's PB Ratio or its related term are showing as below:

TSE:7079' s PB Ratio Range Over the Past 10 Years
Min: 2.04   Med: 5.15   Max: 9.62
Current: 2.13

During the past 7 years, WDB coco Co's highest PB Ratio was 9.62. The lowest was 2.04. And the median was 5.15.

TSE:7079's PB Ratio is ranked worse than
50.49% of 610 companies
in the Healthcare Providers & Services industry
Industry Median: 2.1 vs TSE:7079: 2.13

During the past 12 months, WDB coco Co's average Book Value Per Share Growth Rate was 33.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 30.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 33.60% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of WDB coco Co was 42.80% per year. The lowest was 29.20% per year. And the median was 35.25% per year.

Back to Basics: PB Ratio


WDB coco Co PB Ratio Historical Data

The historical data trend for WDB coco Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WDB coco Co PB Ratio Chart

WDB coco Co Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial 4.56 6.03 6.05 4.15 3.11

WDB coco Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.39 4.12 3.41 3.11 2.32

Competitive Comparison of WDB coco Co's PB Ratio

For the Health Information Services subindustry, WDB coco Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WDB coco Co's PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where WDB coco Co's PB Ratio falls into.



WDB coco Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

WDB coco Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=3445.00/1597.928
=2.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


WDB coco Co  (TSE:7079) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


WDB coco Co PB Ratio Related Terms

Thank you for viewing the detailed overview of WDB coco Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


WDB coco Co Business Description

Traded in Other Exchanges
N/A
Address
1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co Headlines

No Headlines